Methods for treating Angelman syndrome and related disorders
US11273218B2 · kind B2 · utility
0Cited by
10References
9Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Oct 24, 2016 |
| Grant date | Mar 15, 2022 |
| Priority date | — |
| Expiry date | Aug 28, 2037 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K2039/505
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Provided herein are methods of treating Angelman Syndrome and/or Prader-Willi syndrome, that include administering an effective amount of a T-type calcium channel antagonist to a subject in need of the treatment.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.